Clinical Microbiology and Antimicrobial Chemotherapy. 2025; 27(2):238-248
Objective. To analyze physicians’ preferences regarding the pharmacotherapy of bacterial genitourinary infections (UTI) in pregnant women and assess their compliance with current clinical guidelines.
Materials and Methods. The study was conducted over 2018–2022 using an anonymous questionnaire method among physicians in seven regions of Russia. A total of 227 healthcare providers participated, of whom 66.8% were general practitioners and 33.2% were obstetricians/gynecologists.
Results. According to the analysis, there is an insufficient level of knowledge in the field of pharmacotherapy of UTIs in pregnant women.